Sarah Burdett

Summary

Affiliation: National Institute for Medical Research
Country: UK

Publications

  1. ncbi request reprint Publication bias and meta-analyses: a practical example
    Sarah Burdett
    Meta analysis Group, Medical Research Council Clinical Trials Unit, London, UK
    Int J Technol Assess Health Care 19:129-34. 2003
  2. ncbi request reprint Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis
    Sarah Burdett
    Meta analysis Group, MRC Clinical Trials Unit, 222 Euston Road, London NW12DA, UK
    Lung Cancer 47:81-3. 2005
  3. ncbi request reprint A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer
    Sarah Burdett
    Meta analysis Group, MRC Clinical Trials Unit, London, United Kingdom
    J Thorac Oncol 1:611-21. 2006
  4. doi request reprint Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London WC2B 6NH, UK
    BMJ 346:f1798. 2013
  5. ncbi request reprint Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer
    Lesley Stewart
    Meta analysis Group, Medical Research Council Clinical Trials Unit, London, UK
    Cancer Treat Rev 31:487-90. 2005
  6. pmc Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics
    Jack Bowden
    MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK
    BMC Med Res Methodol 11:41. 2011
  7. ncbi request reprint A comparison of the results of checked versus unchecked individual patient data meta-analyses
    Sarah Burdett
    Int J Technol Assess Health Care 18:619-24. 2002
  8. ncbi request reprint Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis
    Sarah Burdett
    J Thorac Cardiovasc Surg 129:1205; author reply 1205-6. 2005
  9. ncbi request reprint Meta-analysis when only the median survival times are known: a comparison with individual patient data results
    Stefan Michiels
    Department of Public Health, Institut Gustave Roussy, Villejuif Cedex, France
    Int J Technol Assess Health Care 21:119-25. 2005
  10. ncbi request reprint Chemotherapy in non-small-cell lung cancer: an update of an individual patient data meta-analysis
    Sarah Burdett
    J Clin Oncol 23:924-5; author reply 925-6. 2005

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Publication bias and meta-analyses: a practical example
    Sarah Burdett
    Meta analysis Group, Medical Research Council Clinical Trials Unit, London, UK
    Int J Technol Assess Health Care 19:129-34. 2003
    ..quot; However, excluding such trials from systematic reviews could introduce bias and give rise to misleading conclusions...
  2. ncbi request reprint Postoperative radiotherapy in non-small-cell lung cancer: update of an individual patient data meta-analysis
    Sarah Burdett
    Meta analysis Group, MRC Clinical Trials Unit, 222 Euston Road, London NW12DA, UK
    Lung Cancer 47:81-3. 2005
    ..There continues to be evidence that the effects of PORT are more harmful in those patients with stage I disease than those with stage II disease...
  3. ncbi request reprint A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer
    Sarah Burdett
    Meta analysis Group, MRC Clinical Trials Unit, London, United Kingdom
    J Thorac Oncol 1:611-21. 2006
    ..The effectiveness of preoperative chemotherapy in the treatment of non-small cell lung cancer has remained unclear despite the conduct of several randomized controlled trials (RCTs)...
  4. doi request reprint Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews
    Claire L Vale
    Meta analysis Group, MRC Clinical Trials Unit, London WC2B 6NH, UK
    BMJ 346:f1798. 2013
    ..To evaluate the reliability of risk of bias assessments based on published trial reports, for determining trial inclusion in meta-analyses...
  5. ncbi request reprint Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer
    Lesley Stewart
    Meta analysis Group, Medical Research Council Clinical Trials Unit, London, UK
    Cancer Treat Rev 31:487-90. 2005
  6. pmc Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics
    Jack Bowden
    MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, UK
    BMC Med Res Methodol 11:41. 2011
    ..In recent years, alternative methods for quantifying heterogeneity have been proposed, that are based on a 'generalised' Q statistic...
  7. ncbi request reprint A comparison of the results of checked versus unchecked individual patient data meta-analyses
    Sarah Burdett
    Int J Technol Assess Health Care 18:619-24. 2002
    ..We therefore aimed to assess the utility of data checking by investigating whether checks made any appreciable difference to the results of an individual patient data meta-analysis...
  8. ncbi request reprint Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis
    Sarah Burdett
    J Thorac Cardiovasc Surg 129:1205; author reply 1205-6. 2005
  9. ncbi request reprint Meta-analysis when only the median survival times are known: a comparison with individual patient data results
    Stefan Michiels
    Department of Public Health, Institut Gustave Roussy, Villejuif Cedex, France
    Int J Technol Assess Health Care 21:119-25. 2005
    ..We aimed to evaluate retrospectively the performance of meta-analyses using median survival times and survival rates by comparing them with meta-analyses using IPD to calculate HRs...
  10. ncbi request reprint Chemotherapy in non-small-cell lung cancer: an update of an individual patient data meta-analysis
    Sarah Burdett
    J Clin Oncol 23:924-5; author reply 925-6. 2005
  11. ncbi request reprint Chemotherapy for high-grade glioma
    Sarah Burdett
    Neuroepidemiology 22:366. 2003
  12. ncbi request reprint Letter to the editor
    Sarah Burdett
    Lung Cancer 48:149-50. 2005